Article Versions Notes

Papagiannis D, Perlepe G, Tendolouri T, Karakitsiou P, Damagka G, Kalaitzi A, Alevra S, Malli F, Gourgoulianis KI. Proportion of Respiratory Syncytial Virus, SARS-CoV-2, Influenza A/B, and Adenovirus Cases via Rapid Tests in the Community during Winter 2023—A Cross Sectional Study. Diseases. 2023; 11(3):122. https://doi.org/10.3390/diseases11030122

Papagiannis, Dimitrios, Garifallia Perlepe, Theodora Tendolouri, Polyxeni Karakitsiou, Georgia Damagka, Anna Kalaitzi, Sofia Alevra, Foteini Malli, and Konstantinos I. Gourgoulianis. 2023. "Proportion of Respiratory Syncytial Virus, SARS-CoV-2, Influenza A/B, and Adenovirus Cases via Rapid Tests in the Community during Winter 2023—A Cross Sectional Study" Diseases 11, no. 3: 122. https://doi.org/10.3390/diseases11030122

Papagiannis, D., Perlepe, G., Tendolouri, T., Karakitsiou, P., Damagka, G., Kalaitzi, A., Alevra, S., Malli, F., & Gourgoulianis, K. I. (2023). Proportion of Respiratory Syncytial Virus, SARS-CoV-2, Influenza A/B, and Adenovirus Cases via Rapid Tests in the Community during Winter 2023—A Cross Sectional Study. Diseases, 11(3), 122. https://doi.org/10.3390/diseases11030122